Company Profile:
Granules India Limited is a manufacturing company (factory).
Granules India Limited is an Indian pharmaceutical company that operates as a vertically integrated manufacturer. It primarily focuses on the production of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages. The company is involved in the entire value chain from API manufacturing to finished products, serving various markets globally.
Enterprise Products
Granules India Limited manufactures and sells a range of pharmaceutical products including:
Active Pharmaceutical Ingredients (APIs):
Paracetamol (Acetaminophen)
Ibuprofen
Metformin Hydrochloride
Guaifenesin
Methocarbamol
Ranitidine Hydrochloride
Fexofenadine Hydrochloride
Naproxen
Caffeine
Cetirizine Hydrochloride
Famotidine
Gabapentin
Levetiracetam
Oxybutynin Chloride
Tramadol Hydrochloride
Venlafaxine Hydrochloride
Pharmaceutical Formulation Intermediates (PFIs):
These are ready-to-compress or ready-to-fill formulations of the APIs, such as Paracetamol PFI, Ibuprofen PFI, and Metformin PFI.
Finished Dosages (FDs):
These include various dosage forms like tablets, capsules, and oral solutions containing the aforementioned APIs. Examples are Paracetamol tablets, Ibuprofen tablets, Metformin tablets, Guaifenesin tablets, Methocarbamol tablets, Fexofenadine tablets, and Naproxen tablets.